4//SEC Filing
Parisotto Shannon M 4
Accession 0001127602-24-005831
CIK 0001100682other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 5:32 PM ET
Size
23.1 KB
Accession
0001127602-24-005831
Insider Transaction Report
Form 4
Parisotto Shannon M
CEVP, Disc & Safety Assessment
Transactions
- Sale
Common Stock
2024-02-15$237.20/sh−291$69,025→ 8,187 total - Sale
Common Stock
2024-02-15$239.28/sh−1,290$308,671→ 6,897 total - Sale
Common Stock
2024-02-15$240.12/sh−1,617$388,274→ 5,280 total - Sale
Common Stock
2024-02-15$241.28/sh−610$147,181→ 4,670 total - Sale
Common Stock
2024-02-15$242.43/sh−632$153,216→ 4,038 total - Sale
Common Stock
2024-02-15$243.96/sh−604$147,352→ 3,434 total - Sale
Common Stock
2024-02-15$244.61/sh−749$183,213→ 2,685 total - Sale
Common Stock
2024-02-15$245.34/sh−89$21,835→ 2,596 total - Exercise/Conversion
Common Stock
2024-02-15$144.67/sh+5,882$850,949→ 8,478 total - Exercise/Conversion
Stock Options (Right to Buy)
2024-02-15−5,882→ 0 totalExercise: $144.67From: 2020-02-22Exp: 2024-02-22→ Common Stock (5,882 underlying)
Holdings
- 29,406(indirect: By LLC)
Common Stock
Footnotes (9)
- [F1]Reflects the exempt transfer pursuant to Rule 16a-13 of 370 shares held by the reporting person to Karpathos Investments LLC.
- [F2]This transaction was executed in multiple trades at prices ranging from $236.71 to $237.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
- [F3]This transaction was executed in multiple trades at prices ranging from $238.73 to $239.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
- [F4]This transaction was executed in multiple trades at prices ranging from $239.76 to $240.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
- [F5]This transaction was executed in multiple trades at prices ranging from $240.83 to $241.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
- [F6]This transaction was executed in multiple trades at prices ranging from $241.97 to $242.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
- [F7]This transaction was executed in multiple trades at prices ranging from $243.26 to $244.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
- [F8]This transaction was executed in multiple trades at prices ranging from $244.27 to $45.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
- [F9]This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
Documents
Issuer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CIK 0001100682
Entity typeother
Related Parties
1- filerCIK 0001952784
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 5:32 PM ET
- Size
- 23.1 KB